Baolingbao BiologyLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Sijue Dai

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentage	n/a
CEO tenure	3.2yrs
CEO ownership	n/a
Management average tenure	6.1yrs
Board average tenure	3.2yrs

Recent management updates

Recent updates

CEO

Sijue Dai (28 yo)

3.2yrs

Tenure

CN¥1,406,900

Compensation

Mr. Sijue Dai serves as a Non-Independent Director at Baolingbao Biology Co., Ltd. since March 15, 2021 and serves as its Chairman and has been its General Manager.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sijue Dai	GM & Chairman	no data	CN¥1.41m	no data
Yanjun Wang	CFO & Deputy GM	6.1yrs	no data	no data
Xia Li	Deputy General Manager	no data	CN¥544.60k	0.0088% CN¥ 203.7k
Feng Liu	Executive Deputy GM & Non-Independent Director	13.3yrs	CN¥894.00k	0.013% CN¥ 305.6k
Guogang Zhang	Deputy GM & Secretary of the Board of Directors	3.2yrs	CN¥611.70k	0.016% CN¥ 361.0k

6.1yrs

Average Tenure

49yo

Average Age

Experienced Management: 002286's management team is seasoned and experienced (6.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Sijue Dai	GM & Chairman	3.2yrs	CN¥1.41m	no data
Feng Liu	Executive Deputy GM & Non-Independent Director	13.3yrs	CN¥894.00k	0.013% CN¥ 305.6k
YuHai Su	Supervisor	3.2yrs	CN¥70.00k	no data
Yongqiang Huang	Independent Director	7.1yrs	CN¥70.00k	0.0027% CN¥ 62.8k
Hongbo Li	Vice Chairman	3.7yrs	CN¥1.02m	0.012% CN¥ 271.7k
Cuiping Qin	Non-Independent Director	5.3yrs	CN¥985.50k	0.012% CN¥ 271.7k
Yurun He	Independent Director	3.2yrs	CN¥70.00k	no data
Hao Zhou	Supervisor	3.2yrs	no data	no data
Xin Chen	Independent Director	2.7yrs	CN¥70.00k	no data
Bei Xu	Chairman of Board of Supervisors	1.4yrs	no data	no data
Qiang Wang	Director	no data	no data	0.027% CN¥ 634.0k

3.2yrs

Average Tenure

50yo

Average Age

Experienced Board: 002286's board of directors are considered experienced (3.2 years average tenure).

Baolingbao BiologyLtd Management

Management criteria checks 3/4

Key information

Recent management updates

Baolingbao Biology Co.,Ltd. Approves Directorate Appointments

Baolingbao Biology Co.,Ltd., Annual General Meeting, Feb 28, 2024

High number of new directors

High number of new and inexperienced directors

Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections

Recent updates

Baolingbao Biology Co.,Ltd. Approves Directorate Appointments

First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.05 in 1Q 2023)

Investor sentiment deteriorates as stock falls 19%

Baolingbao Biology Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024

New minor risk - Earnings quality

Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023

Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.36 in FY 2022)

Baolingbao Biology Co.,Ltd., Annual General Meeting, Feb 28, 2024

Investor sentiment deteriorates as stock falls 18%

Baolingbao Biology Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 07, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.057 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.041 (vs CN¥0.13 in 2Q 2022)

Investor sentiment improves as stock rises 17%

Baolingbao Biology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 20 June 2023

Full year 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.55 in FY 2021)

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.27 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Baolingbao Biology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 27, 2022

Baolingbao Biology Co.,Ltd. Announces Final Cash Dividend for the Year 2021

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CN¥17.55

High number of new and inexperienced directors

Price target decreased to CN¥17.55

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.03 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.079 in 2Q 2020)

Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Payment Date on June 3, 2021

Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.04 in 1Q 2020)

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020

Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections

New 90-day low: CN¥9.17

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: CN¥10.52

Market pulls back on stock over the past week

Third quarter earnings released

New 90-day low: CN¥13.71

First half earnings released

New 90-day high - CN¥19.77

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age